|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,583,000 |
Market
Cap: |
N/A |
Last
Volume: |
1,917,000 |
Avg
Vol: |
889,275 |
52
Week Range: |
$259.55 - $259.55 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Duggan Robert W |
Chairman and CEO |
|
2010-06-21 |
4 |
B |
$6.51 |
$6,999,995 |
D/D |
1,075,268 |
10,904,702 |
3.23 |
- |
|
Rice Glenn C |
Director |
|
2010-02-12 |
4 |
OE |
$0.91 |
$182,000 |
D/D |
200,000 |
605,944 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2010-01-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(33,500) |
602,714 |
|
- |
|
Bamdad Cynthia |
Director |
|
2010-01-20 |
4 |
S |
$4.16 |
$20,574 |
D/D |
(4,950) |
0 |
|
- |
|
Bamdad Cynthia |
Director |
|
2010-01-20 |
4 |
OE |
$1.94 |
$9,603 |
D/D |
4,950 |
4,950 |
|
- |
|
Bamdad Cynthia |
Director |
|
2010-01-19 |
4 |
S |
$4.22 |
$27,830 |
D/D |
(6,600) |
0 |
|
- |
|
Bamdad Cynthia |
Director |
|
2010-01-19 |
4 |
OE |
$1.31 |
$11,203 |
D/D |
6,600 |
4,058 |
|
- |
|
Bamdad Cynthia |
Director |
|
2010-01-14 |
4 |
S |
$4.16 |
$317,887 |
D/D |
(76,329) |
0 |
|
- |
|
Bamdad Cynthia |
Director |
|
2010-01-14 |
4 |
OE |
$0.81 |
$72,508 |
D/D |
76,329 |
76,329 |
|
- |
|
Adelman Jason T |
Director |
|
2009-12-31 |
4 |
OE |
$1.24 |
$31,500 |
D/D |
25,403 |
25,403 |
|
- |
|
Van Den Broek Richard |
Director |
|
2009-12-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
138,730 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2009-12-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(12,900) |
636,214 |
|
- |
|
Buggy Joseph J |
VP, Research |
|
2009-10-30 |
4 |
A |
$1.66 |
$1,658 |
D/D |
1,000 |
6,000 |
|
- |
|
Loury David J |
Vice President of Development |
|
2009-10-30 |
4 |
A |
$1.06 |
$1,063 |
D/D |
1,000 |
1,000 |
|
- |
|
Hamdy Ahmed Md |
Chief Medical Officer |
|
2009-10-30 |
4 |
A |
$1.06 |
$1,063 |
D/D |
1,000 |
1,000 |
|
- |
|
Rice Glenn C |
President and COO |
|
2009-10-30 |
4 |
A |
$1.06 |
$1,063 |
D/D |
1,000 |
405,944 |
|
- |
|
Erdtmann Rainer M |
VP of Finance |
|
2009-10-30 |
4 |
A |
$1.06 |
$1,063 |
D/D |
1,000 |
1,000 |
|
- |
|
Smith David Duane |
Director |
|
2009-08-05 |
4 |
OE |
$1.28 |
$408 |
D/D |
319 |
2,000 |
|
- |
|
Rice Glenn C |
President and COO |
|
2009-08-05 |
4 |
OE |
$1.28 |
$400,000 |
D/D |
312,500 |
404,944 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2009-07-31 |
4 |
OE |
$1.28 |
$170,691 |
I/I |
133,352 |
649,112 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2009-07-31 |
4 |
OE |
$1.28 |
$6,086,234 |
D/D |
4,754,870 |
9,829,434 |
|
- |
|
Rice Glenn C |
President and COO |
|
2009-07-31 |
4 |
OE |
$1.28 |
$47,928 |
D/D |
37,444 |
92,444 |
|
- |
|
Smith David Duane |
Director |
|
2009-07-31 |
4 |
OE |
$1.28 |
$872 |
D/D |
681 |
1,681 |
|
- |
|
Buggy Joseph J |
VP, Research |
|
2009-04-30 |
4 |
A |
$1.06 |
$1,063 |
D/D |
1,000 |
5,000 |
|
- |
|
Rice Glenn C |
Director |
|
2008-12-31 |
4 |
A |
$0.79 |
$3,950 |
D/D |
5,000 |
55,500 |
|
- |
|
385 Records found
|
|
Page 12 of 16 |
|
|